Resident Care

Hormone-targeting Alzheimer’s trial ready to begin as final patient selected

Final patient will complete trial in 4 months (3 months on treatment with a follow-up 1 month after treatment).

Read More >>

Recent animal trials predict ability to cut Alzheimer’s, dementia in half

n the animal trials researchers said the experimental vaccine showed it could delay the effects of the degenerative brain disease.

Read More >>

Upcoming study shows the real strength of an MRI in Alzheimer’s prediction

The disease affects 5.5 million Americans, according to the National Institutes of Health.

Read More >>

Arizona sheriff’s office plans dementia-related registry

Sheriff Doug Schuster said he’d like to have such a registry started next spring. 

Read More >>

Baylor presents latest report on Alzheimer’s

Update to patients and caregivers featured two papers linking Alzheimer's and herpes viruses.

 
Read More >>

Weighing the cost: treating or ignoring hearing loss in seniors

Having hearing loss and not knowing it might translate into higher medical bills and other health problems for many seniors, two new studies suggest.

 
 
Read More >>

Five-minute neck scan seems to detect dementia much earlier, research shows

Researchers have shown that early dementia signs could be detected by a simple short scan of the individual’s neck. 

Read More >>

THC reduces Alzheimer’s-like brain changes in mice

A substance that gives pot its kick appears to reduce the brain changes associated with Alzheimer's disease – at least in mice.

Read More >>

Certain dementia drugs may quicken Alzheimer’s symptoms, decline

“Clinical trials of new therapies for [Alzheimer’s disease] typically allow participants to continue receiving [cholinesterase inhibitors] and memantine during the trial if the dose remains stable,” Richard E. Kennedy, MD, PhD.

Read More >>

New study shows signs of Alzheimer’s treatment with diabetes drug

A new study finds that people with Alzheimer's disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition.

Read More >>